title: Analysis of adaptive response to bleomycin and mitomycin C.
abstract: Genetic instability resulting from the disturbances in various mechanisms of DNA-repair is the characteristic feature of cancer cells. One of the possibilities to evaluate the effectiveness of DNA-repair system is the adaptive response (AR) analysis. The AR is a phenomenon by which cells exposed to low, non-genotoxic doses of a mutagen become significantly resistant to a subsequent higher dose of the same or another genotoxic agent. Generally, it is postulated that AR is related to a reduction of damage by the induction of free radical detoxification and/or DNA-repair systems. The existence of various DNA-repair mechanisms poses the question whether there are differences in AR induced by chemicals causing DNA-damage that requires different pathways for its repair. In this paper we present the study on the AR induced by two chemical mutagens, bleomycin (BLM) and mitomycin C (MMC), which differ in their action on DNA. BLM is a radiomimetic agent causing mainly single-strand breaks (SSB) and double-strand breaks (DSB) and, thus, inducing chromosomal aberrations (CA). MMC is a potent bifunctional mutagen acting as an alkylating agent, causing DNA cross-links and inducing sister chromatid exchanges (SCEs). The protective effect induced by low doses of tested chemicals was analysed in whole blood human lymphocytes using cytogenetic endpoints (CA for BLM and SCE for MMC, respectively) as a measure of chromosomal instability. There was a significant difference between the protective effects induced by BLM and MMC in the lymphocytes of the same group of donors. The pre-treatment with a low dose of BLM-induced almost 50% decrease in the frequency of CA induced by challenging dose (CD), while the protective effect of MMC was below 20%. The higher AR induced by BLM may be related to the repair processing of BLM-induced DNA-damages. There was also a variability in ARs among individuals, which may reflect the differences in individual DNA-repair capacity.
authors.affiliation: Department of Genetics, Wroclaw Medical University, Marcinkowskiego 1, 50-368 Wroclaw, Poland.
authors.forename: Kamila
authors.initials: K
authors.lastname: Schlade-Bartusiak
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Stembalska-Kozlowska
authors.forename: Monika
authors.initials: M
authors.lastname: Bernady
authors.forename: Marta
authors.initials: M
authors.lastname: Kudyba
authors.forename: Maria
authors.initials: M
authors.lastname: Sasiadek
mesh_terms: D000222:Adaptation, Physiological; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002869:Chromosome Aberrations; D004260:DNA Repair; D005260:Female; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000494:pharmacology*; D012854:Sister Chromatid Exchange
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D016685:Mitomycin